Six years after the FDA approved…
Six years after the FDA approved Eli Lilly’s Retevmo to [...]
Determined to avoid a repeat of…
Determined to avoid a repeat of the supply shortfalls that [...]
Friday’s RFI sets a March 19…
Friday’s RFI sets a March 19 deadline for stakeholders to [...]
A new campaign for Astellas…
A new campaign for Astellas Pharma’s Izervay is aimed at [...]
Vertex expects $500 million in…
Vertex expects $500 million in 2026 from new products outside [...]
The regulatory environment in the…
The regulatory environment in the United States encountered by Moderna [...]
It’s déjà vu all over again….
It’s déjà vu all over again. Just as the IgA [...]
Late Thursday, PTC revealed that…
Late Thursday, PTC revealed that it withdrew its FDA application [...]
Bayer has cooked up the next phase…
Bayer has cooked up the next phase of its “See [...]
Eli Lilly and Innovent Biologics…
Eli Lilly and Innovent Biologics have deepened their ties with [...]